Analgesic responses to intrathecal morphine in relation to CSF concentrations of morphine-3,beta-glucuronide and morphine-6,beta-glucuronide (Q39438630)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Analgesic responses to intrathecal morphine in relation to CSF concentrations of morphine-3,beta-glucuronide and morphine-6,beta-glucuronide	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Analgesic responses to intrathecal morphine in relation to CSF concentrations of morphine-3,beta-glucuronide and morphine-6,beta-glucuronide (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

author name string

G C Dennis

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

D Soni

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

O Dehkordi

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

R M Millis

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

H James

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

W L West

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

R E Taylor

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1725-1731

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Recent advances in the treatment of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Long-term pain relief produced by intrathecal morphine infusion in 53 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Chronic intrathecal morphine for intractable pain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Persistent pain associated with long-term intrathecal morphine administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Human brain metabolism of morphine and naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Extrahepatic morphine metabolism in man during the anhepatic phase of orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Morphine-3-glucuronide--a potent antagonist of morphine analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Morphine, morphine-6-glucuronide and morphine-3-glucuronide concentrations in plasma and cerebrospinal fluid during long-term high-dose intrathecal morphine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Potential analgesic contribution from morphine-6-glucuronide in CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Pain characterization in cancer patients and the analgetic response to epidural morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Morphine-6-glucuronide has high affinity for the opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Morphine-6-glucuronide, a potent mu agonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Analgesic Effect of Morphine Glucuronides

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Paradoxical pain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidation

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Characterization of paracetamol UDP-glucuronosyltransferase activity in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Opioid receptor upregulation and supersensitivity in mice: effect of morphine sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

The Edmonton staging system for cancer pain: preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900110-1

7 January 2021

Identifiers

10.1016/S0024-3205(99)00110-1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39438630&oldid=1827961840"